InvestorsHub Logo
icon url

drkazmd65

09/23/10 3:30 PM

#3628 RE: nybuild1 #3627

nybuild - as I posed about a week ago,...

Go back to post #3564 and read it,... Short answer to your question is they are just getting rolling on the Phase III testing.

They just got approval to start the trials so if you were looking for instant stock share price gratification you will be disappointed.

If - on the other hand - you can afford to hang out a while and wait things out - the investment might be worth it.



My guess,... this PR is getting out and better known, along with the fact that no negative PR has come out to counteract it,.. and the two are adding up to draw some at least short term interest in CVM.
icon url

roger wilco

09/23/10 6:38 PM

#3629 RE: nybuild1 #3627

Institutional buying will now start to kick in as Phase 3 clinicals get underway. Comparable companies trading on the market are on average $4-5 a share. That is where this is headed.